Embecta Corp.
EMBC
NASDAQ·Healthcare·Medical - Instruments & Supplies·Mkt cap $344.1M
$5.80
▲ +1.93%
P/E
2.49
Mkt Cap
$344.1M
52-Wk Range
$2.77–$15.55
52-Week Range
$2.77 - $15.55
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 60.4% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- 100-year heritage and brand recognition in diabetes care
- Integrated portfolio combining hardware devices with digital health solutions
- Established distribution network across US and international markets
- Specialized focus on diabetes management versus diversified competitors
Bear Case
1 risk
- Average volatility.
Growth
Mild headwinds expected
Rising global diabetes prevalence and patient population growth
Value
Deep value opportunity - significant discount to Large Cap Pharma peers
Momentum
Hot
+73.7% over 3m
Quality
Strong
Excellent business quality
Dividend
High yield
5.52% yield
Smart-money signal
Who's buying EMBC right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 24, 2026
AUG 7, 2026
Reported EPS of $0.56 vs $0.27 consensus (+110.7% surprise). Revenue of $271.7M vs $254.5M expected (+6.8%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+110.7%
Revenue trend · last 8Q
—
—
-6%
-10%
+8%
-8%
-0%
-8%
Q3 24
Q4 24
Q1 24
Q2 25
Q3 25
Q4 25
Q1 25
Q3 26
$272.5M
$286.1M
$261.9M
$259.0M
$295.5M
$264.0M
$261.2M
$271.7M
Margins · last 8Q
Gross
52.3%
Operating
17.9%
Profit
7.8%
Wall Street consensus
3 analysts · 0% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
0%
Hold
67%
Sell
33%
Median Price Target
—
Latest: Bank of America · May 18, 2026
vs Industry
How EMBC stacks vs Medical - Instruments & Supplies
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related